Ormat Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares NYSE:ORA


(MENAFN – GlobeNewsWire – Nasdaq) RENO, Nevada, Nov. 30, 2020 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) (‘Ormat’ or the ‘Company’), a leading vertically integrated company that is primarily engaged in the geothermal and recovered energy generation (‘REG’) businesses, as well the solar photovoltaic (PV) and energy storage and management services business, today announced the full exercise of the underwriters’ option to purchase an additional 622,500 shares of common stock at the public offering price of $74.00 per share in connection with the Company’s previously announced public offering of common stock. After giving effect to the full exercise of the option to purchase additional shares, the total number of shares sold by Ormat in the public offering was 4,772,500 shares resulting in net proceeds of approximately $340 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

‘We are delighted to have successfully completed

Read More

Ormat Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares


The MarketWatch News Department was not involved in the creation of this content.

RENO, Nevada, Nov 30, 2020 (GLOBE NEWSWIRE via COMTEX) —
RENO, Nevada, Nov. 30, 2020 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) (“Ormat” or the “Company”), a leading vertically integrated company that is primarily engaged in the geothermal and recovered energy generation (“REG”) businesses, as well the solar photovoltaic (PV) and energy storage and management services business, today announced the full exercise of the underwriters’ option to purchase an additional 622,500 shares of common stock at the public offering price of $74.00 per share in connection with the Company’s previously announced public offering of common stock. After giving effect to the full exercise of the option to purchase additional shares, the total number of shares sold by Ormat in the public offering was 4,772,500 shares resulting in net proceeds of approximately $340 million, after deducting underwriting

Read More

Ormat Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares


RENO, Nevada, Nov. 30, 2020 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) (“Ormat” or the “Company”), a leading vertically integrated company that is primarily engaged in the geothermal and recovered energy generation (“REG”) businesses, as well the solar photovoltaic (PV) and energy storage and management services business, today announced the full exercise of the underwriters’ option to purchase an additional 622,500 shares of common stock at the public offering price of $74.00 per share in connection with the Company’s previously announced public offering of common stock. After giving effect to the full exercise of the option to purchase additional shares, the total number of shares sold by Ormat in the public offering was 4,772,500 shares resulting in net proceeds of approximately $340 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

“We are delighted to have successfully completed our public offering,” commented Doron

Read More

Don’t Just Sit There: A Little Exercise Makes Up for a Full Day of Sitting


It may seem harmless, but sitting for long periods of time can take years off your life. Yet a little physical activity can make a life-saving difference.

Researchers have found a direct relationship between excessive sedentary time and an early death. Between stay-at-home behaviors compounded by the COVID-19 pandemic and with holiday season upon us, individuals run the risk of becoming more inactive as major feasting and relaxation take over.

The good news: A new study published in theBritish Journal of Sports Medicine has found that a short amount of exercise each day can offset those harmful effects.

In a meta-analysis of nine previous investigations involving more than 44,000 middle-aged and older men and women (who recorded their physical activity with fitness trackers), scientists discovered that 30 to 40 minutes per day of “moderate to vigorous intensity physical activity” could counteract the negative health effects of sitting still for

Read More

Vision Marine Technologies Announces Closing of Initial Public Offering of Common Shares and Full Exercise of Underwriters Over-Allotment Option


Montreal, Canada – ( NewMediaWire ) – November 27, 2020 – Vision Marine Technologies Inc. (Nasdaq: VMAR), the leading provider of electric technology in the design and manufacture of the first fully electric powertrain outboard motor (E-Motion) and electric power boats, today announced the closing of its initial public offering of 2,760,000 common shares at a price of US$10.00 per share, which includes 360,000 shares sold upon full exercise of the underwriter’s option to purchase additional common shares. The gross proceeds from the offering, including the exercise of the over-allotment option, were US$27,600,000, before deducting underwriting discounts, commissions and offering expenses. 

ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the offering.  

Vision intends to use the net proceeds from the offering for sales and marketing, build-up of inventory for order fulfillment, research and development, development of rental operations, and general working capital.

A registration

Read More

Tiga Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Units


SINGAPORE–(BUSINESS WIRE)–Nov 27, 2020–

Tiga Acquisition Corp. (the “Company”) (NYSE: TINV.U) today announced the closing of its initial public offering of 27,600,000 units, which includes 3,600,000 units issued upon the exercise of the underwriters’ overallotment option, which was exercised in full, at a public offering price of $10.00 per unit, resulting in gross proceeds of $276 million. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. The units began trading on the NYSE under the symbol “TINV.U” on November 24, 2020. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on the NYSE under the symbols “TINV” and “TINV WS,” respectively.

The Company is led

Read More

Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares


SAN DIEGO, Nov. 24, 2020 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the closing of its initial public offering of 69,000,000 shares of Class A common stock, including the full exercise of the underwriters’ option to purchase up to 9,000,000 additional shares of Class A common stock, at a public offering price of $27 per share. The aggregate gross proceeds to Maravai from the offering were approximately $1,863,000,000, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were offered by Maravai. Maravai’s Class A common stock began trading on the Nasdaq Global Select Market on November 20, 2020 under the symbol “MRVI.”

Morgan Stanley, Jefferies and Goldman Sachs & Co. LLC acted as joint book-running managers for the offering. BofA Securities,

Read More

Reed’s Inc. Announces Closing of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares


The MarketWatch News Department was not involved in the creation of this content.

NORWALK, Conn., Nov 24, 2020 (GLOBE NEWSWIRE via COMTEX) —
NORWALK, Conn., Nov. 24, 2020 (GLOBE NEWSWIRE) — Reed’s Inc. (Nasdaq: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced it has closed its previously announced underwritten public offering of 18,750,000 shares and the full exercise of the underwriters’ option to purchase an additional 2,812,500 shares. In total, the Company issued 21,562,500 of its common stock at a price of $0.56 per share for gross proceeds of approximately $12.1 million. Included within the total offering amount, members of Reed’s Board of Directors and senior management invested in the aggregate of approximately $625,000.

“The success of this offering and insider participation is a testament to our collective confidence in our long-term growth potential. We are driving accelerated growth, driven by strong execution and innovation

Read More

Silver Elephant Announces Closing of C$9.2 Million Bought Deal Public Offering, Including Full Exercise of the Over-Allotment Option


The MarketWatch News Department was not involved in the creation of this content.

November 24, 2020 (ACCESSWIRE via COMTEX) —
Not for distribution to U.S. news wire services or dissemination in the United States.

VANCOUVER, BC / ACCESSWIRE / November 24, 2020 / Silver Elephant Mining Corp. (“Silver Elephant” or the “Company”) (TSX:ELEF)(OTCQX:SILEF)(Frankfurt:1P2N) is pleased to announce the closing of its bought deal short form prospectus offering pursuant to which the Company has issued 23,000,000 common shares of the Company (the “Common Shares”) at a price of C$0.40 per Common Share, for aggregate gross proceeds of C$9,200,000 (the “Offering”), including the full exercise of the over-allotment option.

The Offering was led by Mackie Research Capital Corporation as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters, including Canaccord Genuity Corp. and Sprott Capital Partners LP.

The net proceeds from the Offering will be used for the exploration,

Read More

Stoke Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares


The MarketWatch News Department was not involved in the creation of this content.

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced the closing of its underwritten public offering of 2,875,000 shares of its common stock, including 375,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares, at a price to the public of $39.00 per share. The net proceeds from the offering were approximately $105.1 million, after deducting underwriting discounts and commissions and estimated offering expenses.

J.P. Morgan Securities LLC, Cowen and Company, LLC, and Credit Suisse Securities (USA) LLC acted as joint book-running managers in the offering. Canaccord Genuity LLC and Cantor Fitzgerald & Co. acted as passive bookrunners in the offering.

Stoke intends to use the net proceeds from the proposed offering, together with its

Read More